Stay positive and happy. Work hard!
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$RGBP NEWS! Regen BioPharma, Inc. Addresses Potential Impact of Recent Bristol Myers Squibb $2.3 Billion Acquisition of IFM Therapeutics
Small molecule biotech companies fetching trophy values from large Pharma
SAN DIEGO, August 9, 2017 /PRNewswire/ --
Regen BioPharma Inc. (RGBP) and (RGBPP) sees recent deal activity in the immune oncology space as an indication that big pharma continues to place significant bets on the ability of biotech companies to create the innovation they seek.
On August 3, 2017 Bristol Myers Squibb (BMS) announced that it had entered into an agreement to acquire IFM Therapeutics, a smaller biotech company focused on developing therapies that modulate novel targets in the innate immune system to treat cancer, autoimmunity and inflammatory disorders. Pursuant to the agreement, IFM Therapeutics is to receive $300 million upfront with the potential of up to an additional $2.02 billion in milestone payments (https://investors.bms.com/iframes/press-releases/press-release-details/2017/Bristol-Myers-Squibb-to-Acquire-IFM-Therapeutics-to-Strengthen-Oncology-Pipeline-Focus-on-Innate-Immunity/default.aspx).
IFM has developed pre-clinical small molecule activators and inhibitors that modulate the immune system. Their small molecules are designed to be used as anti-cancer drugs and against autoimmune disorders.
"While the targets of IFM's small molecules are entirely different from those of Regen's NR2F6 program, the disease programs and the small molecule approach are similar," said Harry Lander, Ph.D., President and Chief Scientific Officer of Regen BioPharma Inc. "It is evident that the need for novel small molecules to attack these diseases is great and that novel targets, like NR2F6, are very important."
"We are probably six months to one year behind the development stage of IFM's program, but we are optimistic our target and compounds will provide similar interest among drug makers in the immune oncology and autoimmunity space," said David Koos, Ph.D., Chairman and CEO of Regen BioPharma Inc.
About Regen BioPharma Inc.:
Regen BioPharma Inc. is a publicly traded biotechnology company (RGBP) and (RGBPP). The Company is focused on the immunology and immunotherapy space. The Company is focused on rapidly advancing novel technologies through pre-clinical and Phase I/ II clinical trials. Currently, the Company is focused on small molecule therapies for treating cancer and autoimmune disorders. Additional information on Regen BioPharma is available at http://www.regenbiopharmainc.com.
Disclaimer: This news announcement may contain forward-looking statements. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward looking statements are subject include, but are not limited to, the effect of government regulation, competition and other material risks.
CONTACT INFORMATION
Regen BioPharma Inc.
David R. Koos, Ph.D.
Chairman & Chief Executive Officer
+1-619-702-1404 Phone
+1-619-330-2328 Fax
david.koos@regenbiopharma.com
Regen BioPharma, Inc. (OTC Trading Symbol: RGBP)
Website: http://www.regenbiopharmainc.com/
RGBP is focused on the immunology and immunotherapy space. The Company plans to rapidly advance novel technologies through pre-clinical and Phase I/ II clinical trials. Currently, the Company is advancing small molecule therapies for treating cancer and autoimmune disorders by modulating the Checkpoint NR2F6. The company also developing products treating blood disorders using small molecules and gene silencing (DiffronC), treating cancer with cellular immunotherapy (dCellVax), modulating key molecular processes in cancer stem cell through its patented molecular targeting approaches (BORIS), and repairing damaged bone marrow in patients with aplastic anemia and chemotherapy/radiotherapy treated cancer patients (HemaXellerate).
Comprehensive FPS Profile link including EVERYTHING you want to know on RGBP including recent updates, PR's, Quote, stock price, ETC:
http://www.frontpagestocks.com/regen-biopharma-inc-rgbp/
$NAKD back on radar and looks ready for a nice bounce from here!
Dwyane Wade talk about Naked on #ESPN http://www.mybeststockpicks.com/nakd-story/ http://www.espn.com/nba/story/_/page/bodydwyanewade/miami-heat-guard-dwyane-wade-insecurities-injuries-outies-body-issue-2016 https://www.thestreet.com/video/13191583.html
$MFST Medifirst Solutions Signs Distribution Agreement
FREEHOLD, NJ--(Marketwired - Aug 4, 2017) - MEDIFIRST SOLUTIONS, INC. ( OTC PINK : MFST ) (the "Company" or "Medifirst"), a provider of innovative laser technology with its FDA 510(k) cleared Infrared Time Machine TTML-8102000 Laser Thermal Therapeutic Device, is pleased to announce that it has signed a distribution agreement with an international distribution company based in the Middle East that has the rights for the following territories: Lebanon, Kuwait, Saudi Arabia, United Arab Emirates, Bahrain, Qatar, Oman, Jordan and Iraq. During the term of this Agreement, the distributor has the first-right-of-refusal to expand the territory in order to distribute the products on an exclusive basis in Egypt, Cyprus and Turkey. Its distribution arm includes established medical distribution companies in the region: Medica Group, Gulf Drug, and Arabian Ethicals.
https://finance.yahoo.com/news/medifirst-solutions-signs-distribution-agreement-180717583.html
Medifirst Solutions, Inc. (OTC Trading Symbol: MFST)
Website: www.medifirst.com
MFST in response to its Premarket Notification 510(k) submission for The Time Machine Series Laser, received clearance from the U.S. Food and Drug Administration to market its infrared Time Machine TTML-8102000 Laser Thermal Therapeutic Device. The Time Machine Series Lasers Model TTML-8102000 - 810/830nm is intended for use in temporary relief of minor muscle and joint pain, stiffness, minor arthritis pain, muscle spasm, temporary increase in local blood circulation and temporary relaxation of muscles by means of topical elevated tissue temperature from infrared spectral emissions. Due to the decrease of inflammation, patients have seen immediate aesthetic improvements as well, such as in scar healing and incisions. The hand-held laser device, with pin-point accuracy, often gives patients immediate results with no redness, swelling or down-time. This unique laser device offers medical professionals an affordable and effective tool to enhance their treatment protocols for their patients and provide new revenue streams for their practice. The laser division will be operated out of Medifirst's wholly owned subsidiary, Medical Lasers Manufacturer
Comprehensive FPS Profile link including EVERYTHING you want to know on MFST including recent updates, PR's, Quote, stock price, ETC:
http://www.frontpagestocks.com/medifirst-solutions-mfst/
$AFOM Featured in Forbes. https://bit.ly/2tJ5ebk
$AFOM Parental Communication helps resolve and prevent bullying
@CFBMovie is produced for both generations. https://www.stopbullying.gov/what-you-can-do/parents/index.html
$ARNH big acquisition news here
ARNH Closes Acquisition of Intensity Nutrition
FORT LAUDERDALE, FL / ACCESSWIRE / July 31, 2017 / The Automotive Resource Network Holdings Corp (OTC PINK: ARNH), is pleased to announce that as of close of business day July 25th 2017. The company has successfully closed a transaction to acquire 100% interest of Intensity Nutrition Supplement Company.
(http://intensitynutrition.com/).
Founded by a former Navy SEAL and a group of hardcore functional fitness enthusiasts, Intensity Nutrition develops nutritional products for athletes who train and operate at the highest thresholds of athletic performance. Special operators and those who train at ultra-high intensity require unique nutritional support - and SEALs are famous for the intensity of their workouts. As one of our teammates put it, "If you're not an eyes-watering, snot-running, drooling mess at the end of a workout, you didn't do it right." To "do it right" often includes augmenting a sound nutritional program with supplements. Maintaining a perfect diet (which IS important) isn't always achievable for an athlete with operational constraints or an accelerated training regimen.
"Functional and tactical athletes need lean muscle mass, explosive strength, and power for sudden, high-stress, high-performance situations. At Intensity we are proud to deliver the highest quality supplements on the market, and look forward to Introducing a new line of functional Innovative new product lines," stated CEO of Intensity, Mr. Leonard K Armenta Jr.
Intensity's Mission
Founded by a former Navy SEAL and a group of hardcore functional fitness enthusiasts, Intensity Nutrition develops nutritional products, (at this moment a line of 5 products), for athletes who train and operate at the highest thresholds of athletic performance.
To "do it right" often includes augmenting a sound nutritional program with supplements - unless you have the time to delicately measure your food intake six to eight times per day. Following the healthiest diet (which IS important) isn't always achievable for an athlete with a fast-paced lifestyle or accelerated training regimen.
We've found that NONE of the existing products on the market meet our needs. Functional and tactical athletes don't need to "bulk up" or run or bike a hundred miles at a time. We need lean muscle mass, explosive strength, and power for sudden, high-stress, high-performance situations.
So when we created the INTENSITY line of products, we focused on providing the right ingredients, in the right amounts, to give you everything you need and nothing you don't. That means:
• Exceptional quality
• Effective ingredients in clinically effective doses
• Dye free, Incredible flavors
• NO "pixie dust" or "window dressing "
• NO illegal, unsafe junk of any kind
You get only the highest quality proteins, carbohydrates, vitamins and minerals - the stuff your body is designed to run on.
Our products are manufactured in an audited facility, and both our products and our facility conform to the following guidelines:
• WADA
• NCAA
• US Military
• USADA
• Certified GMP
• Informed Choice Certified
In addition to the acquisition effective July 25th, CEO David Failla resigned and appointed Mr. Leonard K Armenta Jr, as the new incoming CEO of (ARNH), effective immediately.
"I want to thank outgoing CEO David Failla and his team for supporting The Automobile Resource Network Holding Inc. for bringing the company current and up to date to achieve this transaction. In Conclusion, I look forward to working with investors, shareholders and future innovators to develop new and exciting nutritional products," stated Leonard K Armenta Jr.
$ARNH has successfully closed a transaction to acquire 100% interest of Intensity Nutrition Supplement Company. http://intensitynutrition.com/ https://finance.yahoo.com/news/arnh-closes-acquisition-intensity-nutrition-120000561.html
$ARNH Big acquisition news !!!
The company has successfully closed a transaction to acquire 100% interest of Intensity Nutrition Supplement Company. https://finance.yahoo.com/news/arnh-closes-acquisition-intensity-nutrition-120000561.html
$PVHO after the dip can we see new *HOD* some of $PVHO partners include AT&T, Google, Intel, IBM and the list goes on. This is just warming up! http://www.fastmovingstocks.com/pvho-basing-chart-major-catalysts-pick/ http://ir.provision.tv/
Is $CVAT the Next Household Name in Wine and Spirits? https://www.equities.com/news/is-cvat-the-next-household-name-in-wine-and-spirits
$PVHO Basing on the Chart as Major Catalysts Pick Up http://www.fastmovingstocks.com/pvho-basing-chart-major-catalysts-pick/
$PVHO Prosperity Investments Selects Provision Interactive’s 3D Holographic Technology to be Integrated into Prosperity’s ATM Banking Systems’ Global Deployment https://finance.yahoo.com/news/prosperity-investments-selects-provision-interactive-113000508.html
$AFOM will be our biggest stock pick yet, it is a publicly traded company on the OTCQB, NOT the PINKSHEETS! Fully reporting, all transparent, low float, shooting a movie that MAJOR Players are in, such as:
White House Communications Director Anthony Scaramucci!
http://variety.com/2017/biz/news/anthony-scaramucci-investment-anti-bullying-movie-crazy-for-the-boys-1202508484/
Press galore and when the movie crazy for the boys comes out next spring break we see massive gains:
http://savannahnow.com/news/2017-07-06/crazy-boys-new-teen-musical-drama-films-diner-abercorn
CRAZY FOR THE BOYS will be a modern day "GREASE" for AFOM, Bank on it! See weeks 1 & 2 filming clips here exclusively:
$AFOM Anthony Scaramucci’s Hollywood Ties for White House newcomer $250,000 Investment in Movie ‘Crazy for the Boys’ http://variety.com/2017/biz/news/anthony-scaramucci-investment-anti-bullying-movie-crazy-for-the-boys-1202508484/
$AFOM will be our biggest stock pick yet, it is a publicly traded company on the OTCQB, NOT the PINKSHEETS! Fully reporting, all transparent, low float, shooting a movie that MAJOR Players are in, such as:
White House Communications Director Anthony Scaramucci!
http://variety.com/2017/biz/news/anthony-scaramucci-investment-anti-bullying-movie-crazy-for-the-boys-1202508484/
Press galore and when the movie crazy for the boys comes out next spring break we see massive gains:
http://savannahnow.com/news/2017-07-06/crazy-boys-new-teen-musical-drama-films-diner-abercorn
CRAZY FOR THE BOYS will be a modern day "GREASE" for AFOM, Bank on it! See weeks 1 & 2 filming clips here exclusively:
$CODX Co-Diagnostics, Inc. Verifies Zika CoPrimer™ Test https://finance.yahoo.com/news/co-diagnostics-inc-verifies-zika-114500842.html
$CODX has completed principle design and verification of its #Zika test built on the Company’s CoPrimer™ technology. http://globenewswire.com/news-release/2017/07/27/1063416/0/en/Co-Diagnostics-Inc-Verifies-Zika-CoPrimer-Test.html
$CODX Co-Diagnostics, Inc. Verifies Zika CoPrimer™ Test
http://globenewswire.com/news-release/2017/07/27/1063416/0/en/Co-Diagnostics-Inc-Verifies-Zika-CoPrimer-Test.html
$INCC officially launches its website and ecommerce
store: BluDogProducts.com
$RGBP Regen BioPharma Inc. (RGBP) and (RGBPP) today reported continued progress in Regen's development of small molecule drugs that activate and inhibit NR2F6. https://finance.yahoo.com/news/regen-biopharma-inc-research-demonstrates-120000740.html
$ENTB NEWS: Zander Therapeutics, Inc. Reports Research Demonstrating Ex-Vivo Immune Suppression of IL-17a and IL-2 in Dogs With Novel NR2F6 Activators https://finance.yahoo.com/news/zander-therapeutics-inc-reports-research-134500614.html
$ENTB reported that researchers for $RGBP have identified what the company believes to be a strong activator for modulating checkpoint NR2F6. https://finance.yahoo.com/news/zander-therapeutics-inc-reports-research-134500614.html
$CODX NEWS SALT LAKE CITY--(BUSINESS WIRE)--Co-Diagnostics, Inc. (NASDAQ: CODX) (“Co-Diagnostics” or the “Company”), a molecular diagnostics company that has a unique, proprietary platform for the development of diagnostic tests, officially announced today the recent incorporation of CoSara Diagnostics, Pvt., Ltd., a Joint Venture for manufacturing with Synbiotics Limited. Synbiotics is a group company of Asence Inc, a U.S. incorporated company specializing in supplying pharmaceutical products to international markets. http://www.businesswire.com/news/home/20170725005266/en/Co-Diagnostics-Announces-Joint-Venture-India
$RGBP News is out: Regen BioPharma, Inc. Research Demonstrates Ex-Vivo Immune Suppression With Novel NR2F6 Activators https://finance.yahoo.com/news/regen-biopharma-inc-research-demonstrates-120000740.html
$CODX News is out: Co-Diagnostics, Inc. Announces Joint Venture in India http://www.businesswire.com/news/home/20170725005266/en/Co-Diagnostics-Announces-Joint-Venture-India
$CODX tests for tuberculosis, hepatitis B and C, malaria, HIV and Zika virus will be among those initially developed and marketed by the Company. http://www.mybeststockpicks.com/codx-shares-huge-opportunity/
$AFOM Take a look at their Video from week one
$AFOM CRAZY FOR THE BOYS // Listening Party
$AFOM From L.A. to Savannah, Georgia, the cast and crew of the upcoming movie musical 'Crazy for the Boys' got a chance to hang out and listen to the movie's soundtrack for the first time before shooting began!
$AFOM Video from week one
*$AFOM* Video from week one
$LTEA Combines Growth, a Tiny Float, and an Advantageous Chart Setup http://www.mybeststockpicks.com/ltea-combines-growth-tiny-float-advantageous-chart-setup/
$LTEA News Long Island Iced Tea Corp. Continues International Expansion, Begins Asia/Pacific Focus by Announcing Distribution Partnership for New Zealand and the Pacific Islands https://finance.yahoo.com/news/long-island-iced-tea-corp-120000976.html
$LTEA Long Island Iced Tea Corp. Continues International Expansion, Begins Asia/Pacific Focus by Announcing Distribution Partnership for New Zealand and the Pacific Islands https://finance.yahoo.com/news/long-island-iced-tea-corp-120000976.html
$LTEA Long Island Iced Tea continues international expansion: https://finance.yahoo.com/news/long-island-iced-tea-corp-120000976.html
$SCTFF US Cobalt Provides Progress Update at the Iron Creek Cobalt Project https://finance.yahoo.com/news/us-cobalt-provides-progress-iron-080000902.html
$SCTFF US Cobalt Provides Progress Update at the Iron Creek Cobalt Project https://finance.yahoo.com/news/us-cobalt-provides-progress-iron-080000902.html
$USCO $SCTFF Cobalt Demand Surges as Tesla Begins Model 3 Battery Production http://wallstreetnation.com/breaking-news/elon-musk-worst-nightmare-no-cobalt-no-tesla.html
$USCO $SCTFF US Cobalt Provides Progress Update at the Iron Creek Cobalt Project https://finance.yahoo.com/news/us-cobalt-provides-progress-iron-080000902.html
$USCO.V $SCTFF Cobalt Demand Surges as Tesla Begins Model 3 Battery Production http://wallstreetnation.com/breaking-news/elon-musk-worst-nightmare-no-cobalt-no-tesla.html